3 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Nuevocor Competitors or Alternatives

Nuevocor's top competitors include XyloCor, Lexeo and Tenaya.

Unlock 23 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Nuevocor's company profile

Yann Chong Tan

Founder & CEO

90/100
1 - 25
$24M
$100K - 5M
  • $24M
    $100K - 5M
  • 1 - 25
    $24M
  • $100K - 5M
  • 90/100
  • 1 - 25
  • $24M
  • $100K - 5M
View ProfileView
1
Nuevocor's Competitor - XyloCor logo

Albert Gianchetti

President & CEO

90/100
1 - 25
$110.1M
$5M - 25M
  • $110.1M
    $5M - 25M
  • 1 - 25
    $110.1M
  • $5M - 25M
  • 90/100
  • 1 - 25
  • $110.1M
  • $5M - 25M
View ProfileView
2
Nuevocor's Competitor - Lexeo logo

R. Nolan Townsend

CEO

90/100
72
$380M
$ < 1M
  • $380M
    $ < 1M
  • 72
    $380M
  • $ < 1M
  • 90/100
  • 72
  • $380M
  • $ < 1M
View ProfileView
3
Nuevocor's Competitor - Tenaya logo

Faraz Ali

CEO

90/100
110
$511M
  • $511M
  • 110
    $511M
  • 90/100
  • 110
  • $511M
View ProfileView
4
Nuevocor's Competitor - Cytokinetics logo

Robert I Blum

President & CEO

90/100
250
$1.8B
$18.5M
  • $1.8B
    $18.5M
  • 250
    $1.8B
  • $18.5M
  • 90/100
  • 250
  • $1.8B
  • $18.5M
View ProfileView
5
Nuevocor's Competitor - HeartFlow logo

John Farquhar

President & CEO

84/100
250 - 500
$1.4B
$25M - 100M
  • $1.4B
    $25M - 100M
  • 250 - 500
    $1.4B
  • $25M - 100M
  • 84/100
  • 250 - 500
  • $1.4B
  • $25M - 100M
View ProfileView
Nuevocor's top 26 competitors are XyloCor, Lexeo, Tenaya, Renova Therapeutics, Cytokinetics, HeartFlow, Verve, Kriya, Cardurion, Taysha, Intellia, MyoKardia, Esperion, Maze, DiNAQOR, Gemphire Therapeutics, uniQure, Precigen, XBiotech, Renovacor, BioMarin, Ra Pharma, Rocket Pharma, Critical Diagnostics, StrideBio and Apellis. Together they have raised over 13.1B between their estimated 39.4K employees. Nuevocor's revenue is the ranked 22th among it's top 10 competitors. The top 10 competitors average 2.1B. Nuevocor has 10 employees and is ranked 25th among it's top 10 competitors. The top 10 competitors average 1,514.

Nuevocor VS XyloCor

XyloCor is Nuevocor's #1 competitor. XyloCor's headquarters is in Wayne, Pennsylvania, and was founded in 2013. Like Nuevocor, XyloCor also works within the Pharmaceuticals sector. XyloCor generates 509% of Nuevocor's revenue.

Nuevocor VS Lexeo

Lexeo is one of Nuevocor's top rivals. Lexeo was founded in New York, New York} in 2018. Lexeo operates in the Biotechnology industry. Compared to Nuevocor, Lexeo generates $346K less revenue.

Nuevocor VS Tenaya

Tenaya is one of Nuevocor's top competitors. Tenaya is a Public company that was founded in 2016 in South San Francisco, California. Tenaya is in the Biotechnology industry. Compared to Nuevocor, Tenaya has 100 more employees.

Looking for similar companies to Nuevocor?

Similar Companies

Pharmaceuticals companies in Central Singapore

See 64 companies 
Biotechnology companies in Central Singapore

See 112 companies 
Pharmaceuticals companies in Singapore

See 104 companies 
Pharmaceuticals & Biotechnology companies in Central Singapore

See 174 companies 
Biotechnology companies in Singapore

See 182 companies 
Pharmaceuticals & Biotechnology companies in Singapore

See 275 companies 
Companies in Central Singapore with employees in 1-25 range

See 1,361 companies 
Companies in Central Singapore with revenue in $100K-5.0M range

See 1,803 companies 
Companies in Singapore with employees in 1-25 range

See 2,043 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Nuevocor and Nuevocor's Competitors

April 17, 2025Investing.com
uniQure shares soar on FDA breakthrough therapy designation...
April 18, 2025Nasdaq
Good news from the laboratory and a clutch of bullish analyst notes were the drivers behind Verve Therapeautics' (NASDAQ: VERV) big stock price leap th...
April 17, 2025Benzinga
uniQure's AMT-130 receives FDA Breakthrough Therapy designation for Huntington's disease, adding to Fast Track, RMAT, and Orphan Drug statuses. read mo...

Frequently Asked Questions about Nuevocor

  1. Who are Nuevocor's top competitors?

    Nuevocor's top 3 competitors are XyloCor, Lexeo, Tenaya.

  2. Who is similar to Nuevocor?

    XyloCor is the most similar to Nuevocor. Lexeo and Tenaya are also similar to Nuevocor.

  1. Are Nuevocor and XyloCor competitors?

    Yes, XyloCor is one of Nuevocor’s top competitors.